Journal of Cancer Research and Therapeutics Close
 

Figure 1: Overall survival (in months) from time of primary diagnosis in all 27 patients with brain metastases from small-cell lung cancer. The actuarial 6 months and 12 months overall survival rates were 70% and 52%, respectively

Figure 1: Overall survival (in months) from time of primary diagnosis in all 27 patients with brain metastases from small-cell lung cancer. The actuarial 6 months and 12 months overall survival rates were 70% and 52%, respectively